Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2008 Filed Apr 2, 2008 22:30 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionCommon shares without par value | 5,124 | $33.95 | $173,961.34 |
DisclosureSEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 1 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:29 UTC |
DALEY WILLIAM MDirector
|
GrantStock Equivalent Units · Derivative | 435 | $55.15 Strike: $0.00 | $23,990.25 |
DisclosureSEC source: 0001104659-08-022151 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,181 Underlying: Common shares · 435 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:29 UTC |
FULLER H LAURANCEDirector
|
GrantStock equivalent units · Derivative | 489 | $55.15 Strike: $0.00 | $26,968.35 |
DisclosureSEC source: 0001104659-08-022152 · a4.xml · derivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,323 Underlying: Common Shares · 489 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:29 UTC |
OSBORN WILLIAM ADirector
|
GrantStock equivalent units · Derivative | 290 | $55.15 Strike: $0.00 | $15,993.50 |
DisclosureSEC source: 0001104659-08-022153 · a4.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290 Underlying: Common shares · 290 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:29 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 271 | $55.15 Strike: $0.00 | $14,945.65 |
DisclosureSEC source: 0001104659-08-022154 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,086 Underlying: Common shares · 271 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:30 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock Equivalent Units · Derivative | 516 | $55.15 Strike: $0.00 | $28,457.40 |
DisclosureSEC source: 0001104659-08-022155 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,330 Underlying: Common shares · 516 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:30 UTC |
TILTON GLENN FDirector
|
GrantStock equivalent units · Derivative | 462 | $55.15 Strike: $0.00 | $25,479.30 |
DisclosureSEC source: 0001104659-08-022156 · a4.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,723 Underlying: Common shares · 462 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:30 UTC |
SCOTT SAMUEL C IIIDirector
|
GrantStock equivalent units · Derivative | 462 | $55.15 Strike: $0.00 | $25,479.30 |
DisclosureSEC source: 0001104659-08-022157 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,723 Underlying: Common Shares · 462 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 28, 2008 Filed Mar 28, 2008 22:26 UTC |
OWEN DAVIDDirector
|
SaleCommon shares without par value | 1,306 | $53.31 | $69,619.99 |
DisclosureSEC source: 0001104659-08-020852 · a4.xml · nonDerivative · entry 2 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,706 Read SEC document |
| March 27, 2008 Filed Mar 28, 2008 21:00 UTC |
Bohuon OlivierSenior Vice President
|
GrantOption (right to buy) · Derivative | 26,311 | $0.00 Strike: $54.03 | $0.00 |
DisclosureSEC source: 0001104659-08-020811 · a4.xml · derivative · entry 4 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,311 Underlying: Common shares · 26,311 shares Expires 2013-05-31 F1 · security: Employee stock option, including replacement option feature granted pursuant to Abbott Laboratories Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 27, 2008 Filed Mar 28, 2008 21:00 UTC |
Bohuon OlivierSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 34,023 | $0.00 Strike: $41.78 | $0.00 |
DisclosureSEC source: 0001104659-08-020811 · a4.xml · derivative · entry 3 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 34,023 shares Expires 2013-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option, including replacement option feature granted pursuant to Abbott Laboratories Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 27, 2008 Filed Mar 28, 2008 21:00 UTC |
Bohuon OlivierSenior Vice President
|
Tax withholdingCommon shares without par value | 26,311 | $54.03 | $1,421,583.33 |
DisclosureSEC source: 0001104659-08-020811 · a4.xml · nonDerivative · entry 2 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,342 Read SEC document |
| March 27, 2008 Filed Mar 28, 2008 21:00 UTC |
Bohuon OlivierSenior Vice President
|
Exercise / conversionCommon shares without par value | 34,023 | $41.78 | $1,421,603.42 |
DisclosureSEC source: 0001104659-08-020811 · a4.xml · nonDerivative · entry 1 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2008 Filed Mar 28, 2008 22:26 UTC |
OWEN DAVIDDirector
|
SaleCommon shares without par value | 11,318 | $54.20 | $613,435.60 |
DisclosureSEC source: 0001104659-08-020852 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,012 F1 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 2,983 | $0.00 Strike: $55.66 | $0.00 |
DisclosureSEC source: 0001104659-08-019954 · a4.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,983 Underlying: Common shares · 2,983 shares Expires 2009-02-11 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 9,042 | $0.00 Strike: $55.66 | $0.00 |
DisclosureSEC source: 0001104659-08-019954 · a4.xml · derivative · entry 7 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,042 Underlying: Common shares · 9,042 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,482 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-08-019954 · a4.xml · derivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,482 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,754 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-08-019954 · a4.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 Underlying: Common shares · 10,754 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Schumacher Laura JExecutive Vice President
|
Tax withholdingCommon shares without par value | 12,025 | $55.66 | $669,311.50 |
DisclosureSEC source: 0001104659-08-019954 · a4.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,675 Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 3,482 | $42.50 | $147,977.34 |
DisclosureSEC source: 0001104659-08-019954 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 10,754 | $41.03 | $441,254.90 |
DisclosureSEC source: 0001104659-08-019954 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 21,776 | $0.00 Strike: $55.66 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,776 Underlying: Common Shares · 21,776 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 24,764 | $0.00 Strike: $55.66 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,764 Underlying: Common Shares · 24,764 shares Expires 2009-03-31 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 28,664 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 28,664 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 28,197 | $0.00 Strike: $43.98 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 28,197 shares Expires 2009-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
Tax withholdingCommon shares without par value | 46,540 | $55.66 | $2,590,416.40 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,125 Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 28,664 | $32.61 | $934,764.57 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 28,197 | $43.98 | $1,240,180.19 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 10,321 | $55.41 | $571,896.93 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,804 Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,954 | $0.00 Strike: $42.94 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 17 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,954 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,395 | $0.00 Strike: $42.90 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 16 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,395 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 14,193 | $0.00 Strike: $54.39 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 15 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,193 Underlying: Common shares · 14,193 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 16,672 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 14 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 16,672 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 21,933 | $0.00 Strike: $54.39 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 13 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,933 Underlying: Common shares · 21,933 shares Expires 2014-03-30 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 26,601 | $0.00 Strike: $38.63 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 12 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 26,601 shares Expires 2014-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 31,465 | $0.00 Strike: $54.39 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 11 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,465 Underlying: Common shares · 31,465 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 822 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 822 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Tax withholdingCommon shares without par value | 67,591 | $54.39 | $3,676,274.49 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,210 Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 17,954 | $42.94 | $770,944.76 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 17,395 | $42.90 | $746,245.50 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 16,672 | $41.03 | $684,080.50 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 26,601 | $38.63 | $1,027,484.91 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 822 | $33.23 | $27,316.21 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2008 Filed Mar 21, 2008 15:53 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 1,157 | $55.00 | $63,635.00 |
DisclosureSEC source: 0001104659-08-019002 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,125 Read SEC document |
| March 13, 2008 Filed Mar 18, 2008 00:06 UTC |
SMITHBURG WILLIAM DDirector
|
Exercise / conversionOption (right to buy) · Derivative | 4,422 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001104659-08-018135 · a4.xml · derivative · entry 4 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,422 shares Expires 2008-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 13, 2008 Filed Mar 18, 2008 00:06 UTC |
SMITHBURG WILLIAM DDirector
|
Tax withholdingCommon shares without par value | 2,924 | $51.34 | $150,118.16 |
DisclosureSEC source: 0001104659-08-018135 · a4.xml · nonDerivative · entry 2 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,889 Read SEC document |
| March 13, 2008 Filed Mar 18, 2008 00:06 UTC |
SMITHBURG WILLIAM DDirector
|
Exercise / conversionCommon shares without par value | 4,422 | $33.95 | $150,128.23 |
DisclosureSEC source: 0001104659-08-018135 · a4.xml · nonDerivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 10,604 | $0.00 Strike: $53.24 | $0.00 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,604 Underlying: Common shares · 10,604 shares Expires 2009-02-11 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,236 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 12,236 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,217 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,217 shares Expires 2008-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.